EDAP TMS S.A. (EDAP)
1.38
0.07 (5.34%)
At close: Apr 17, 2025, 3:55 PM
1.38
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT
5.34% (1D)
| Bid | 1.26 |
| Market Cap | 51.6M |
| Revenue (ttm) | 64.2M |
| Net Income (ttm) | -19.04M |
| EPS (ttm) | -0.58 |
| PE Ratio (ttm) | -2.38 |
| Forward PE | -3.29 |
| Analyst | Buy |
| Ask | 1.52 |
| Volume | 38,775 |
| Avg. Volume (20D) | 115,739 |
| Open | 1.30 |
| Previous Close | 1.31 |
| Day's Range | 1.30 - 1.39 |
| 52-Week Range | 1.26 - 7.73 |
| Beta | 0.13 |
About EDAP
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and ma...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 1, 1997
Employees 310
Stock Exchange NASDAQ
Ticker Symbol EDAP
Website https://www.edap-tms.com
Analyst Forecast
According to 3 analyst ratings, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 226.09% from the latest price.
Stock Forecasts1 week ago
-15.71%
Edap TMS shares are trading lower after Jefferies ...
Unlock content with
Pro Subscription
3 weeks ago
+8.29%
EDAP TMS shares are trading higher after the company reported better-than-expected Q4 financial results.
